March 26, 2020 / 10:47 PM / 2 days ago

BRIEF-Equillium Reports Q4 Loss Per Share Of $0.44

March 26 (Reuters) - Equillium Inc:

* EQUILLIUM REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 LOSS PER SHARE $0.44

* Q4 EARNINGS PER SHARE ESTIMATE $-0.39 — REFINITIV IBES DATA

* EQUILLIUM - MAINTAINING GUIDANCE THAT WE ANTICIPATE REPORTING INITIAL DATA FROM EQUATE STUDY DURING SECOND HALF OF 2020

* EQUILLIUM - REITERATE GUIDANCE THAT CASH ON HAND IS SUFFICIENT TO FUND OPERATIONS INTO SECOND HALF OF 2021

* EQUILLIUM - HELD CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALING ABOUT $53.1 MILLION AT DEC 31, 2019

* EQUILLIUM - HAVE PAUSED ENROLLMENT IN THE EQUIP TRIAL FOR UNCONTROLLED ASTHMA AND THE EQUALISE TRIAL FOR LUPUS NEPHRITIS

* EQUILLIUM - REAFFIRMS GUIDANCE TO REPORT INITIAL DATA FROM EQUATE TRIAL IN ACUTE GVHD IN H2 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below